A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)

RECRUITING

Clinique CHC MontLégia, Liège

RECRUITING

Icahn School of Medicine at Mt. Sinai, New York

RECRUITING

MedStar Washington Hospital Center, Washington D.C.

RECRUITING

Prisma Health Cancer Institute - Farris Road, Greenville

RECRUITING

University of Texas Health Science Center of Houston, Houston

RECRUITING

UConn Health, Farmington

RECRUITING

CHU Montreal, Montreal

RECRUITING

St. James Hospital, Dublin